Early detection of gray blight in tea leaves and rapid screening of resistance varieties by hyperspectral imaging technology
Journal of the Science of Food and Agriculture · 2024-12 · 104 (15) · 9336-9348
DOI: 10.1002/jsfa.13756 ↗At a glance
Evaluationsstudie in Journal of the Science of Food and Agriculture, published online on 2024-07-19. Written by Yilin Mao and 7 co-authors. Institution: Tea Research Institute, Shandong Academy of Agricultural Sciences, Jinan, China. Major MEDLINE topics: Plant Leaves, Plant Diseases, Camellia sinensis, Hyperspectral Imaging. Cited 13 times so far (Crossref); 36 references. Funded by: Shandong Academy of Agricultural Sciences, Science and Technology Bureau of Rizhao City, Shandong Provincial Department of Finance.
Abstract (original language)
BACKGROUND Gray blight (GB) is a significant disease of tea leaves, posing a severe threat to both the yield and quality. In this study, the process of leaf infection by a pathogenic isolate of the GB disease (DDZ‐6) was simulated. Hyperspectral images of normal leaves, infected leaves without symptoms, and infected leaves with mild and moderate symptoms were collected. Combining convolution neural network (CNN), long short‐term memory (LSTM), and support vector machine (SVM) algorithms, the early detection model of GB disease, and the rapid screening model of resistant varieties were established. The generality of this method was verified by collecting datasets under field conditions. RESULTS The visible red‐light band demonstrated a pronounced responsiveness to GB disease, with three sensitive bands identified through rigorous screening processes utilizing uninformative variable elimination (UVE), competitive adaptive reweighted sampling (CARS), and the successive projections algorithm (SPA). The 693, 727, and 766 nm bands emerged as highly sensitive indicators of GB. Under ideal conditions, the CARS‐LSTM model excelled in early detection of GB, achieving an accuracy of 92.6%. However, under field conditions, the combination of 693 and 727 nm bands integrated with a CNN provided the most effective early detection model, attaining an accuracy of 87.8%. For screening tea varieties resistant to GB, the SPA‐LSTM model excelled, achieving an accuracy of 82.9%. CONCLUSION This study provides a core algorithm for a GB disease instrument with detection capabilities, which is of great importance for the early prevention of GB disease in tea plantations. © 2024 Society of Chemical Industry.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Tea Research Institute, Shandong Academy of Agricultural Sciences, Jinan, China.
- College of Horticulture, Qingdao Agricultural University, Qingdao, China.
ORCID profiles: Zhaotang Ding
Funding
- Shandong Academy of Agricultural Sciences
- Science and Technology Bureau of Rizhao City
- Shandong Provincial Department of Finance
- Shandong Provincial Natural Science Foundation
- Shandong Provincial People's Government
- Shandong Provincial Finance Department
- Natural Science Foundation of Shandong Province
Cite
APA
Mao, Y., Li, H., Xu, Y., Wang, S., Yin, X., Fan, K., Ding, Z., & Wang, Y. (2024). Early detection of gray blight in tea leaves and rapid screening of resistance varieties by hyperspectral imaging technology. Journal of the Science of Food and Agriculture, 104(15), 9336-9348. https://doi.org/10.1002/jsfa.13756
Vancouver
Mao Y, Li H, Xu Y, Wang S, Yin X, Fan K, et al. Early detection of gray blight in tea leaves and rapid screening of resistance varieties by hyperspectral imaging technology. Journal of the Science of Food and Agriculture. 2024;104(15):9336-9348. doi:10.1002/jsfa.13756
BibTeX
@article{Mao2024,
author = {Mao, Yilin and Li, He and Xu, Yang and Wang, Shuangshuang and Yin, Xinyue and Fan, Kai and Ding, Zhaotang and Wang, Yu},
title = {Early detection of gray blight in tea leaves and rapid screening of resistance varieties by hyperspectral imaging technology},
journal = {Journal of the Science of Food and Agriculture},
year = {2024},
volume = {104},
number = {15},
pages = {9336--9348},
doi = {10.1002/jsfa.13756}
}
EUVIMED